Yuhan touts benefits of promising new P-CAB molecule as it seeks partners
21 October 2011
Ian Haydock
Please Login to read the full article.
21 October 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Mirabegron approved in first market as Gardasil and Rotarix also get formal Japanese nod
- US Capitol Capsule: IOM analysis finds little evidence of vaccine harm, debunks autism link
- Daiichi Sankyo drops ghrelin candidate, sees US olmesartan weakness this year
- Pozen criticises partner AZ as it vows to make aspirin/PPI combo affordable
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
